Most industrial markets in developed countries are mature, with intensive competition among enzyme manufacturers. In order to maintain and expand market share in these countries, manufacturers are continually improving their enzymes to offer efficient performance at lower temperatures and under extreme pH conditions, lower costs via reduced energy and water usage, and produce higher quality end products with larger amounts of marketable co-products. “This continued introduction of new enzyme formulations will sustain growth in demand in mature industrial markets, including the food and beverage, cleaning product, and textile and leather markets,” stated the Freedonia report.
In contrast to industrial markets, the specialty enzyme markets are expanding at a strong pace globally. “While demand for enzymes used in research and biotechnology and in diagnostics is forecast to post strong gains, the fastest growth will be seen for biocatalysts, particularly those used in the production of pharmaceuticals,” observed Christine O’Keefe, analyst, Freedonia Group.
Rising healthcare costs in developed countries have led providers to adopt a ‘personalised’ medicine approach, in which healthcare is tailored to the individual based on clinical profile, genetic background, and personal preferences. This approach to medicine requires the increased use of diagnostic testing as well as genomic sequencing, helping to drive strong demand for diagnostic enzymes. In developing countries, the number of diagnostic tests will increase as the number of insured individuals rises, further supporting growth in demand for the enzymes used in diagnostic testing.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)